Antisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1
Clinical trial NCT06565572 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06565572
- Sponsor
- University of Colorado, Denver
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-23
- Primary completion
- 2024-08-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.